India Grants First Compulsory License To Natco For Bayer’s Nexavar; Disappointed, Bayer May Challenge Decision
This article was originally published in The Pink Sheet Daily
Executive Summary
India grants compulsory license to Natco for Bayer’s Nexavar; ruling could start run on more CLs.